News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
298,512 Results
Type
Article (15892)
Company Profile (114)
Press Release (282506)
Section
Business (96095)
Career Advice (508)
Deals (16645)
Drug Delivery (67)
Drug Development (41534)
Employer Resources (51)
FDA (7656)
Job Trends (6848)
News (166138)
Policy (15589)
Tag
Academia (656)
Alliances (24988)
Alzheimer's disease (440)
Approvals (7669)
Artificial intelligence (82)
Bankruptcy (149)
Best Places to Work (5008)
Breast cancer (112)
Cancer (636)
Cardiovascular disease (61)
Career advice (442)
Cell therapy (80)
Clinical research (34727)
Collaboration (258)
Compensation (101)
COVID-19 (827)
C-suite (84)
Data (622)
Diabetes (94)
Diagnostics (1638)
Drug pricing (61)
Earnings (35257)
Events (42518)
Executive appointments (283)
FDA (8004)
Funding (180)
Gene therapy (88)
GLP-1 (356)
Government (1453)
Healthcare (4891)
Infectious disease (854)
Inflammatory bowel disease (68)
Interviews (63)
IPO (6425)
Job creations (2113)
Job search strategy (404)
Layoffs (189)
Legal (3756)
Lung cancer (96)
Manufacturing (119)
Medical device (2871)
Medtech (2874)
Mergers & acquisitions (10334)
Metabolic disorders (259)
Neuroscience (575)
NextGen: Class of 2025 (1920)
Non-profit (905)
Northern California (683)
Obesity (144)
Opinion (119)
Patents (81)
People (30835)
Pharmaceutical (67)
Phase I (9231)
Phase II (14875)
Phase III (12898)
Pipeline (278)
Postmarket research (1515)
Preclinical (3765)
Radiopharmaceuticals (129)
Rare diseases (133)
Real estate (2804)
Regulatory (11083)
Research institute (753)
Resumes & cover letters (63)
Southern California (649)
Startups (1778)
United States (6415)
Vaccines (136)
Weight loss (102)
Date
Today (62)
Last 7 days (178)
Last 30 days (840)
Last 365 days (14707)
2025 (747)
2024 (14869)
2023 (16851)
2022 (22651)
2021 (23231)
2020 (21951)
2019 (17649)
2018 (13788)
2017 (15778)
2016 (14831)
2015 (17469)
2014 (13906)
2013 (11682)
2012 (12668)
2011 (13223)
2010 (12142)
Location
Africa (325)
Arizona (53)
Asia (21800)
Australia (2956)
California (1586)
Canada (793)
China (196)
Colorado (57)
Connecticut (73)
Delaware (52)
Europe (43421)
Florida (249)
Georgia (57)
Illinois (167)
Indiana (109)
Japan (63)
Kansas (56)
Maryland (237)
Massachusetts (1321)
Minnesota (91)
New Jersey (602)
New York (445)
North Carolina (350)
Northern California (683)
Pennsylvania (390)
South America (539)
Southern California (649)
Texas (209)
Virginia (52)
Washington State (111)
298,512 Results for "endo pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Endo Announces Commencement of OTCQX Trading
Endo, Inc. announced that the Company has commenced trading on the OTCQX® Best Market under the ticker symbol NDOI.
June 28, 2024
·
3 min read
Press Releases
Endo Launches Doxycycline for Injection, USP
December 11, 2024
·
2 min read
Biotech Beach
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
Crinetics Pharmaceuticals, Inc. announced five abstracts from its clinical development programs, including four late-breaking abstracts, will be presented at the Endocrine Society’s annual meeting, ENDO 2024, taking place June 1-4, 2024 in Boston, Massachusetts.
May 8, 2024
·
8 min read
Press Releases
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
December 9, 2024
·
3 min read
Press Releases
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
November 15, 2024
·
4 min read
Business
InnoGI Technologies Announces The Appointment Of Dr. Hajime Endo, Former Chairman And President Of Lonza Japan And JIHFS Board Member, As Strategic Commercial Advisor
InnoGI Technologies, a pioneer and leader in innovative gastrointestinal research, proudly announces the appointment of Dr. Hajime Endo as its Strategic Commercial Advisor.
June 25, 2024
·
3 min read
Biotech Beach
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
Crinetics Pharmaceuticals, Inc. announced that the late-breaking abstracts accepted for presentation at the Endocrine Society’s annual meeting were released earlier than the previously announced embargoed date.
May 22, 2024
·
3 min read
Press Releases
Endo Announces Publication of Peyronie’s Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology
December 16, 2024
·
4 min read
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen’s (formerly Horizon Therapeutics) DUEXIS®.
March 26, 2024
·
13 min read
Business
Endo Reports Fourth-Quarter 2023 Financial Results
Endo International plc reported financial results for the fourth-quarter ended December 31, 2023.
March 6, 2024
·
34 min read
1 of 29,852
Next
